We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diabetes Testing Results Remotely Managed and Monitored

By LabMedica International staff writers
Posted on 28 Sep 2011
Point-of-care (POC) coordinators and laboratory managers can remotely monitor and manage HbA1c and microalbumin testing results using expanded data management solution connectivity.

The new RAPIDComm system is accessible from any computer connected to the hospital-wide network and can be customized to address the needs of different departments, users, and patients. More...
With this system, POC coordinators are able to remotely manage and maximize instrument uptime, simplify instrument control, and operator management.

Siemens Healthcare Diagnostics (Tarrytown, NY, USA) launched the RAPIDComm new data management solution Version 4.0, extending system connectivity to the company’s DCA Vantage diabetes analyzer. The data management system also enhances quality control (QC) management and documentation with automated QC result processing and customizable regulatory reports.

Now point-of-care (POC) laboratory managers are able to rely on a single, advanced user interface to remotely monitor and manage diabetes-testing results, in addition to blood gas via RAPIDSystems, and urinalysis via the CLINITEK Status Connect System. This move further integrates patient data throughout the healthcare network.

With decentralized testing, POC coordinators may be responsible for monitoring large numbers of instruments spread throughout a hospital or various hospital sites, which are operated by several hundred to several thousand operators.

“Healthcare professionals that manage POC testing in hospitals, clinics, and physician offices are increasingly looking to integrate their instruments with a data management solution to reduce transcription errors and better manage data, quality control, and operators, which ultimately helps to improve patient care,” said David Stein, PhD, CEO, Point of Care Business Unit, Siemens Healthcare Diagnostics. “A key priority for Siemens is to continue the innovation of our instruments and data management solutions to provide our POC customers with innovative and flexible connectivity options.”

Related Links:
Siemens Healthcare Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.